Core Needle Biopsy Devices Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Market Dynamics of Core Needle Biopsy Devices Market Analysis

↑ Growth Drivers

  • Rising Cancer Incidence
  • Technological Advancements
  • Increasing Awareness and Screening Programs

↓ Restraints

  • High procedural costs may limit accessibility for healthcare facilities and patients
  • Risk of complications and adverse effects can deter healthcare providers from recommending the procedure

~ Trends

  • Increasing prevalence of cancer globally is driving demand for effective diagnostic procedures
  • Advancements in technology are leading to the development of more precise and less invasive biopsy devices

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Core Needle Biopsy Devices Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx15.2%
North Americaxxxxxxxxxxxx13.4%
United Statesxxxxxxxxxxxx13.2%
Canadaxxxxxxxxxxxx14.2%
Mexicoxxxxxxxxxxxx13.9%
Europexxxxxxxxxxxx13.7%
United Kingdomxxxxxxxxxxxx14.5%
Francexxxxxxxxxxxx12.9%
Germanyxxxxxxxxxxxx13.9%
Italyxxxxxxxxxxxx13.1%
Russiaxxxxxxxxxxxx12.7%
Spainxxxxxxxxxxxx12.8%
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxx12.4%
Asia Pacificxxxxxxxxxxxx17.2%
Chinaxxxxxxxxxxxx16.7%
Japanxxxxxxxxxxxx15.7%
South Koreaxxxxxxxxxxxx16.3%
Indiaxxxxxxxxxxxx19%
Australiaxxxxxxxxxxxx16.9%
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxx17%
South Americaxxxxxxxxxxxx14.6%
Brazilxxxxxxxxxxxx15.2%
Argentinaxxxxxxxxxxxx15.5%
Colombiaxxxxxxxxxxxx14.4%
Peruxxxxxxxxxxxx14.8%
Chilexxxxxxxxxxxx14.9%
Rest of South Americaxxxxxxxxxxxx13.7%
Middle Eastxxxxxxxxxxxx14.9%
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxx14.4%
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxx15.2%
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxx13.9%
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Competitive Landscape of the Core Needle Biopsy Device Market

The competitive landscape of the Core Needle Biopsy Device market is characterized by a diverse range of players, including established medical device manufacturers, specialized biotech companies, and emerging startups. Key industry participants are continuously investing in research and development to innovate and enhance the efficacy and safety of their products.

In Mar 2022, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, opened its Innovation Center today in Aix-en-Provence, France. The new commercial office and training and research and development facility will support Hologic’s ultrasound, interventional, and surgical solutions across the continuum of breast health care . (Source: https://investors.hologic.com/press-releases/press-release-details/2022/Hologic-Opens-New-Innovation-Center-in-France/default.aspx) In April 2021, Unilabs and GE Healthcare signed a partnership agreement. GE Healthcare provides technically advanced MRIs and CT scanning technology, ultrasound devices, mammography, and X-ray machines to Unilabs in Portugal. (Source: https://www.gehealthcare.com/about/newsroom/press-releases/unilabs-and-ge-healthcare-launch-partnership-for-latest-radiology-equipment-and?npclid=botnpclid)

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
ARGON MEDICAL••• ••• ••• •••
Becton Dickinson and Company••• ••• ••• •••
C.R. Bard••• ••• ••• •••
Inc.••• ••• ••• •••
Cook Medical Inc.••• ••• ••• •••
Devicor Medical Products••• ••• ••• •••
Inc.••• ••• ••• •••
F. Hoffmann-La Roche Ltd.••• ••• ••• •••
••• ••• ••• •••
GE Healthcare••• ••• ••• •••
Hologic••• ••• ••• •••
Inc.••• ••• ••• •••
Leica Biosystems••• ••• ••• •••
Medax Srl Unipersonale••• ••• ••• •••
Planmed Oy••• ••• ••• •••
••• ••• ••• •••
Scion Medical Technologies••• ••• ••• •••
LLC••• ••• ••• •••
Siemens Healthier••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was USD 6854.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 15.20% from 2024 to 2031.

  • North America held the major market share for more than 40% of the global revenue with a market size of USD 2741.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
  • Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2056.35 million.
  • Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 1576.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.
  • Latin America had a market share of more than 5% of the global revenue with a market size of USD 342.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.
  • Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 137.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031.
  • The direct sales emerge as the dominant distribution channel. This approach allows manufacturers to maintain close relationships with healthcare providers, ensuring a deeper understanding of their needs and preferences

 

Introduction of the Core Needle Biopsy Device Market

Core needle biopsy devices are specialized instruments used to obtain tissue samples from suspicious lesions for diagnostic purposes. These devices typically consist of a hollow needle that extracts a core of tissue, allowing for histological analysis. They are widely used in various medical fields, including oncology and pathology, for diagnosing cancers and other diseases. The Core Needle Biopsy Device market is poised for significant growth driven by various factors. The increasing incidence of cancer globally necessitates advanced diagnostic tools that can provide timely and accurate results. Moreover, technological advancements in imaging techniques and the development of automated biopsy systems enhance the precision and efficiency of core needle biopsies. The rising awareness of early cancer detection and screening programs further contributes to market expansion.

In November 2020, NeoDynamics AB, a MedTech business dedicated to improving breast cancer diagnosis and treatment, entered a partnership with the Buckinghamshire Healthcare NHS Trust in London for its NeoNavia pulse biopsy technology. (Source: https://www.neodynamics.com/de-de/press-releases/article/4f6e6dd7-ec0c-4b2f-8464-e2494c266e6a/neodynamics-receives-first-uk-order-of-pulse-biopsy-system-neonavia-4f6e6dd7)

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Core Needle Biopsy Devices Market Analysis is witnessing significant growth in the near future.

In 2023, the Full-Automated Core Needle Biopsy Device segment accounted for a notable share of the Core Needle Biopsy Devices Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst at Cognitive Market Research · Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

The global market size for Core Needle Biopsy Device in 2024 is USD 6854.5 million.
The global Core Needle Biopsy Device market is expected to grow with a CAGR of 15.20% over the projected period.
North America held a significant global Core Needle Biopsy Device market revenue share in 2024.
Asia-Pacific will witness the fastest growth of the global Core Needle Biopsy Device market over the coming years.
The US had the most significant global Core Needle Biopsy Device market revenue share in 2024.
The main driver of the growth of the Core Needle Biopsy Device market is the increasing Awareness and Screening Programs.
The Hospitals category dominates the market.

★ Reviews

Rate this report

Core Needle Biopsy Devices Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).

Type Full-Automated Core Needle Biopsy Device, Semi-Automated Core Needle Biopsy Device
Application Hospitals, Clinics, Others
Disease Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer
Range 14G- 18G, 18G
Distribution Channel Direct Sales, Distributor
List of Competitors ARGON MEDICAL, Becton Dickinson and Company, C.R. Bard, Inc., Cook Medical Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd., , GE Healthcare, Hologic, Inc., Leica Biosystems, Medax Srl Unipersonale, Planmed Oy, , Scion Medical Technologies, LLC, Siemens Healthier

  • 1.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      1.1.1 Global Core Needle Biopsy Devices Market Analysis by Key Players
    • 1.1.2 Segment Market Analysis by Key Players
    • 1.1.3 Top Players Ranking 2024
    • 1.1.4 New Product Launch Analysis
    • 1.1.5 Industry Mergers and Acquisition Analysis
  • 1.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.1 ARGON MEDICAL
      • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.1.2 Business Overview
      • 1.2.1.3 Financials (Subject to data availability)
      • 1.2.1.4 R&D Investment (Subject to data availability)
      • 1.2.1.5 Product Types Specification
      • 1.2.1.6 Business Strategy
      • 1.2.1.7 Recent Developments
      • 1.2.1.8 Management Change
      • 1.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.2 Becton Dickinson and Company
      • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.2.2 Business Overview
      • 1.2.2.3 Financials (Subject to data availability)
      • 1.2.2.4 R&D Investment (Subject to data availability)
      • 1.2.2.5 Product Types Specification
      • 1.2.2.6 Business Strategy
      • 1.2.2.7 Recent Developments
      • 1.2.2.8 Management Change
      • 1.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.3 C.R. Bard
      • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.3.2 Business Overview
      • 1.2.3.3 Financials (Subject to data availability)
      • 1.2.3.4 R&D Investment (Subject to data availability)
      • 1.2.3.5 Product Types Specification
      • 1.2.3.6 Business Strategy
      • 1.2.3.7 Recent Developments
      • 1.2.3.8 Management Change
      • 1.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.4 Inc.
      • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.4.2 Business Overview
      • 1.2.4.3 Financials (Subject to data availability)
      • 1.2.4.4 R&D Investment (Subject to data availability)
      • 1.2.4.5 Product Types Specification
      • 1.2.4.6 Business Strategy
      • 1.2.4.7 Recent Developments
      • 1.2.4.8 Management Change
      • 1.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.5 Cook Medical Inc.
      • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.5.2 Business Overview
      • 1.2.5.3 Financials (Subject to data availability)
      • 1.2.5.4 R&D Investment (Subject to data availability)
      • 1.2.5.5 Product Types Specification
      • 1.2.5.6 Business Strategy
      • 1.2.5.7 Recent Developments
      • 1.2.5.8 Management Change
      • 1.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.6 Devicor Medical Products
      • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.6.2 Business Overview
      • 1.2.6.3 Financials (Subject to data availability)
      • 1.2.6.4 R&D Investment (Subject to data availability)
      • 1.2.6.5 Product Types Specification
      • 1.2.6.6 Business Strategy
      • 1.2.6.7 Recent Developments
      • 1.2.6.8 Management Change
      • 1.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.7 Inc.
      • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.7.2 Business Overview
      • 1.2.7.3 Financials (Subject to data availability)
      • 1.2.7.4 R&D Investment (Subject to data availability)
      • 1.2.7.5 Product Types Specification
      • 1.2.7.6 Business Strategy
      • 1.2.7.7 Recent Developments
      • 1.2.7.8 Management Change
      • 1.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.8 F. Hoffmann-La Roche Ltd.
      • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.8.2 Business Overview
      • 1.2.8.3 Financials (Subject to data availability)
      • 1.2.8.4 R&D Investment (Subject to data availability)
      • 1.2.8.5 Product Types Specification
      • 1.2.8.6 Business Strategy
      • 1.2.8.7 Recent Developments
      • 1.2.8.8 Management Change
      • 1.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.9
      • 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.9.2 Business Overview
      • 1.2.9.3 Financials (Subject to data availability)
      • 1.2.9.4 R&D Investment (Subject to data availability)
      • 1.2.9.5 Product Types Specification
      • 1.2.9.6 Business Strategy
      • 1.2.9.7 Recent Developments
      • 1.2.9.8 Management Change
      • 1.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.10 GE Healthcare
      • 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.10.2 Business Overview
      • 1.2.10.3 Financials (Subject to data availability)
      • 1.2.10.4 R&D Investment (Subject to data availability)
      • 1.2.10.5 Product Types Specification
      • 1.2.10.6 Business Strategy
      • 1.2.10.7 Recent Developments
      • 1.2.10.8 Management Change
      • 1.2.10.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.11 Hologic
      • 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.11.2 Business Overview
      • 1.2.11.3 Financials (Subject to data availability)
      • 1.2.11.4 R&D Investment (Subject to data availability)
      • 1.2.11.5 Product Types Specification
      • 1.2.11.6 Business Strategy
      • 1.2.11.7 Recent Developments
      • 1.2.11.8 Management Change
      • 1.2.11.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.12 Inc.
      • 1.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.12.2 Business Overview
      • 1.2.12.3 Financials (Subject to data availability)
      • 1.2.12.4 R&D Investment (Subject to data availability)
      • 1.2.12.5 Product Types Specification
      • 1.2.12.6 Business Strategy
      • 1.2.12.7 Recent Developments
      • 1.2.12.8 Management Change
      • 1.2.12.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.13 Leica Biosystems
      • 1.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.13.2 Business Overview
      • 1.2.13.3 Financials (Subject to data availability)
      • 1.2.13.4 R&D Investment (Subject to data availability)
      • 1.2.13.5 Product Types Specification
      • 1.2.13.6 Business Strategy
      • 1.2.13.7 Recent Developments
      • 1.2.13.8 Management Change
      • 1.2.13.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.14 Medax Srl Unipersonale
      • 1.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.14.2 Business Overview
      • 1.2.14.3 Financials (Subject to data availability)
      • 1.2.14.4 R&D Investment (Subject to data availability)
      • 1.2.14.5 Product Types Specification
      • 1.2.14.6 Business Strategy
      • 1.2.14.7 Recent Developments
      • 1.2.14.8 Management Change
      • 1.2.14.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.15 Planmed Oy
      • 1.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.15.2 Business Overview
      • 1.2.15.3 Financials (Subject to data availability)
      • 1.2.15.4 R&D Investment (Subject to data availability)
      • 1.2.15.5 Product Types Specification
      • 1.2.15.6 Business Strategy
      • 1.2.15.7 Recent Developments
      • 1.2.15.8 Management Change
      • 1.2.15.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.16
      • 1.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.16.2 Business Overview
      • 1.2.16.3 Financials (Subject to data availability)
      • 1.2.16.4 R&D Investment (Subject to data availability)
      • 1.2.16.5 Product Types Specification
      • 1.2.16.6 Business Strategy
      • 1.2.16.7 Recent Developments
      • 1.2.16.8 Management Change
      • 1.2.16.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.17 Scion Medical Technologies
      • 1.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.17.2 Business Overview
      • 1.2.17.3 Financials (Subject to data availability)
      • 1.2.17.4 R&D Investment (Subject to data availability)
      • 1.2.17.5 Product Types Specification
      • 1.2.17.6 Business Strategy
      • 1.2.17.7 Recent Developments
      • 1.2.17.8 Management Change
      • 1.2.17.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.18 LLC
      • 1.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.18.2 Business Overview
      • 1.2.18.3 Financials (Subject to data availability)
      • 1.2.18.4 R&D Investment (Subject to data availability)
      • 1.2.18.5 Product Types Specification
      • 1.2.18.6 Business Strategy
      • 1.2.18.7 Recent Developments
      • 1.2.18.8 Management Change
      • 1.2.18.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.19 Siemens Healthier
      • 1.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.19.2 Business Overview
      • 1.2.19.3 Financials (Subject to data availability)
      • 1.2.19.4 R&D Investment (Subject to data availability)
      • 1.2.19.5 Product Types Specification
      • 1.2.19.6 Business Strategy
      • 1.2.19.7 Recent Developments
      • 1.2.19.8 Management Change
      • 1.2.19.9 S.W.O.T Analysis

  • 2.1 Global Core Needle Biopsy Devices Market Analysis
  • 2.2 Global Core Needle Biopsy Devices Market Analysis by Region
  • 2.3 Global Core Needle Biopsy Devices Market Analysis by Type
  • 2.4 Global Core Needle Biopsy Devices Market Analysis by Application
  • 2.5 Global Core Needle Biopsy Devices Market Analysis by Disease
  • 2.6 Global Core Needle Biopsy Devices Market Analysis by Range
  • 2.7 Global Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 2.8 Global Core Needle Biopsy Devices Market Analysis by Key Players

  • 3.1 North America Core Needle Biopsy Devices Market Analysis
  • 3.2 North America Core Needle Biopsy Devices Market Analysis by Country
  • 3.3 North America Core Needle Biopsy Devices Market Analysis by Type
  • 3.4 North America Core Needle Biopsy Devices Market Analysis by Application
  • 3.5 North America Core Needle Biopsy Devices Market Analysis by Disease
  • 3.6 North America Core Needle Biopsy Devices Market Analysis by Range
  • 3.7 North America Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 3.8 North America Core Needle Biopsy Devices Market Analysis by Key Players

  • 4.1 Europe Core Needle Biopsy Devices Market Analysis
  • 4.2 Europe Core Needle Biopsy Devices Market Analysis by Country
  • 4.3 Europe Core Needle Biopsy Devices Market Analysis by Type
  • 4.4 Europe Core Needle Biopsy Devices Market Analysis by Application
  • 4.5 Europe Core Needle Biopsy Devices Market Analysis by Disease
  • 4.6 Europe Core Needle Biopsy Devices Market Analysis by Range
  • 4.7 Europe Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 4.8 Europe Core Needle Biopsy Devices Market Analysis by Key Players

  • 5.1 Asia Pacific Core Needle Biopsy Devices Market Analysis
  • 5.2 Asia Pacific Core Needle Biopsy Devices Market Analysis by Country
  • 5.3 Asia Pacific Core Needle Biopsy Devices Market Analysis by Type
  • 5.4 Asia Pacific Core Needle Biopsy Devices Market Analysis by Application
  • 5.5 Asia Pacific Core Needle Biopsy Devices Market Analysis by Disease
  • 5.6 Asia Pacific Core Needle Biopsy Devices Market Analysis by Range
  • 5.7 Asia Pacific Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 5.8 Asia Pacific Core Needle Biopsy Devices Market Analysis by Key Players

  • 6.1 South America Core Needle Biopsy Devices Market Analysis
  • 6.2 South America Core Needle Biopsy Devices Market Analysis by Country
  • 6.3 South America Core Needle Biopsy Devices Market Analysis by Type
  • 6.4 South America Core Needle Biopsy Devices Market Analysis by Application
  • 6.5 South America Core Needle Biopsy Devices Market Analysis by Disease
  • 6.6 South America Core Needle Biopsy Devices Market Analysis by Range
  • 6.7 South America Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 6.8 South America Core Needle Biopsy Devices Market Analysis by Key Players

  • 7.1 Middle East Core Needle Biopsy Devices Market Analysis
  • 7.2 Middle East Core Needle Biopsy Devices Market Analysis by Country
  • 7.3 Middle East Core Needle Biopsy Devices Market Analysis by Type
  • 7.4 Middle East Core Needle Biopsy Devices Market Analysis by Application
  • 7.5 Middle East Core Needle Biopsy Devices Market Analysis by Disease
  • 7.6 Middle East Core Needle Biopsy Devices Market Analysis by Range
  • 7.7 Middle East Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 7.8 Middle East Core Needle Biopsy Devices Market Analysis by Key Players

  • 8.1 Africa Core Needle Biopsy Devices Market Analysis
  • 8.2 Africa Core Needle Biopsy Devices Market Analysis by Country
  • 8.3 Africa Core Needle Biopsy Devices Market Analysis by Type
  • 8.4 Africa Core Needle Biopsy Devices Market Analysis by Application
  • 8.5 Africa Core Needle Biopsy Devices Market Analysis by Disease
  • 8.6 Africa Core Needle Biopsy Devices Market Analysis by Range
  • 8.7 Africa Core Needle Biopsy Devices Market Analysis by Distribution Channel
  • 8.8 Africa Core Needle Biopsy Devices Market Analysis by Key Players

  • 9.1 Full-Automated Core Needle Biopsy Device
    • 9.1.1 Global Full-Automated Core Needle Biopsy Device Market
    • 9.1.2 Global Full-Automated Core Needle Biopsy Device Market by Region
  • 9.2 Semi-Automated Core Needle Biopsy Device
    • 9.2.1 Global Semi-Automated Core Needle Biopsy Device Market
    • 9.2.2 Global Semi-Automated Core Needle Biopsy Device Market by Region

  • 10.1 Hospitals
    • 10.1.1 Global Hospitals Market
    • 10.1.2 Global Hospitals Market by Region
  • 10.2 Clinics
    • 10.2.1 Global Clinics Market
    • 10.2.2 Global Clinics Market by Region
  • 10.3 Others
    • 10.3.1 Global Others Market
    • 10.3.2 Global Others Market by Region

  • 11.1 Lung Cancer
    • 11.1.1 Global Lung Cancer Market
    • 11.1.2 Global Lung Cancer Market by Region
  • 11.2 Liver Cancer
    • 11.2.1 Global Liver Cancer Market
    • 11.2.2 Global Liver Cancer Market by Region
  • 11.3 Breast Cancer
    • 11.3.1 Global Breast Cancer Market
    • 11.3.2 Global Breast Cancer Market by Region
  • 11.4 Prostate Cancer
    • 11.4.1 Global Prostate Cancer Market
    • 11.4.2 Global Prostate Cancer Market by Region

  • 12.1 14G- 18G
    • 12.1.1 Global 14G- 18G Market
    • 12.1.2 Global 14G- 18G Market by Region
  • 12.2 18G
    • 12.2.1 Global 18G Market
    • 12.2.2 Global 18G Market by Region

  • 13.1 Direct Sales
    • 13.1.1 Global Direct Sales Market
    • 13.1.2 Global Direct Sales Market by Region
  • 13.2 Distributor
    • 13.2.1 Global Distributor Market
    • 13.2.2 Global Distributor Market by Region

  • 14.1 Market Drivers
  • 14.2 Market Restraints
  • 14.3 Market Trends
  • 14.4 Market Opportunity
  • 14.5 Technological Road Map (Subject to Data Availability)
  • 14.6 Product Life Cycle (Subject to Data Availability)
  • 14.7 Customer and Buyer Behavior Analysis
    • 14.7.1 Consumer Demographics and Target Audience Assessment
    • 14.7.2 Digital Engagement, Customer Experience & Relationship Analysis
    • 14.7.3 Customer Buying Behavior & Purchase Decision Analysis
    • 14.7.4 Vendor Selection, Supplier Preferences & Future Demand Trends
    • 14.7.5 Pricing, Affordability & Value Perception Analysis
    • 14.7.6 Customer Segmentation & Demand Pattern Analysis
  • 14.8 PESTEL Analysis
    • 14.8.1 Political Factors
    • 14.8.2 Economic Factors
    • 14.8.3 Social Factors
    • 14.8.4 Technological Factors
    • 14.8.5 Legal Factors
    • 14.8.6 Environmental Factors
  • 14.9 Industrial Chain Analysis (Subject to Data Availability)
    • 14.9.1 Industry Chain Analysis
    • 14.9.2 Manufacturing Cost Analysis
    • 14.9.3 Supply Side Analysis
      • 14.9.3.1 Raw Material Analysis
      • 14.9.3.2 Raw Material Procurement Analysis
      • 14.9.3.3 Raw Material Price Trend Analysis
  • 14.10 Porter’s Five Forces Analysis
    • 14.10.1 Bargaining Power of Suppliers
    • 14.10.2 Bargaining Power of Buyers
    • 14.10.3 Threat of New Entrants
    • 14.10.4 Threat of Substitutes
    • 14.10.5 Degree of Competition
  • 14.11 Patent Analysis (Subject to Data Availability)
  • 14.12 ESG Analysis
  • 14.13 Geopolitical Outlook
    • 14.13.1 Global Power Realignment & Strategic Alliances
    • 14.13.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 14.13.3 International Trade Relations & Market Access Environment
    • 14.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 14.13.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 14.13.6 Technology Sovereignty & Digital Geopolitics
    • 14.13.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    14.14 AI & Market Transformation
    • 14.14.1 Competitive Landscape Disruption & Strategic Shifts
    • 14.14.2 AI-Driven Transformation of Industry Value Chain
    • 14.14.3 Evolution of Business Models & Revenue Streams
    • 14.14.4 AI-Driven Product, Service & Innovation Transformation
    • 14.14.5 Customer Behavior, AI Adoption & Future Market Evolution

  • 15.1 Country 1
    • 15.2 Country 2
    • 15.3 Country 3
    • 15.4 Country 4
    • 15.5 Country 5
    • 15.6 Country 6
    • 15.7 Country 7
    • 15.8 Country 8
    • 15.9 Country 9
    • 15.10 Country 10

    • 16.1 Key Takeaways

    • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

      16.2 Analyst Point of View
    • 16.3 Assumptions and Acronyms

    • 17.1 Primary Data Collection
      • 17.1.1 Steps for Primary Data Collection
        • 17.1.1.1 Identification of KOL
      • 17.1.2 Backward Integration
      • 17.1.3 Forward Integration
      • 17.1.4 How Primary Research Help Us
      • 17.1.5 Modes of Primary Research
    • 17.2 Secondary Research
      • 17.2.1 How Secondary Research Help Us
      • 17.2.2 Sources of Secondary Research
    • 17.3 Data Validation
      • 17.3.1 Data Triangulation
    • 17.4 Data Representation

    Athenaeum AI Dashboard

    Research Framework · 70:30 Primary:Secondary

    Our Proprietary Methodology

    Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Core Needle Biopsy Devices Market Analysis Market analysis.

    01

    Primary Intelligence Gathering

    Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

    02

    Secondary Data Triangulation

    Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

    03

    Expert Validation Protocol

    Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

    04

    Athenaeum AI Processing

    Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

    05

    Editorial & QA Review

    Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

    Data Assurance Metrics
    Data Points Validated 10,400+
    Expert Interviews 54
    Countries Covered 39+
    Company Profiles 19+
    Forecast Accuracy (Historical) 94.2%
    Report Pages 250+
    Analytical Coverage
    Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

    To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

    Sources from the Medical Devices & Consumables Industry

    How We Serve You

    The Three Pillars of End-to-End Market Research Services

    We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Core Needle Biopsy Devices Market Analysis market.

    Service 01

    Market Survey

    B2B B2C

    Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the core needle biopsy devices market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

    What's Included
    • Buyer intent & sentiment analysis
    • Purchase cycle mapping
    • Price sensitivity research
    • Channel preference profiling
    • Competitive perception study
    Most Requested
    Service 02

    Customized Market Data & Reports

    Custom Ready Report

    Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

    What's Included
    • Ready syndicate report (250+ pages)
    • Custom data scope & segmentation
    • Excel quantitative models
    • Board-ready PPT with key findings
    • Secure cloud portal access
    Service 03

    Strategic Consultation

    With Survey With Report

    Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

    What's Included
    • Dedicated analyst assigned to you
    • Live walkthrough of findings
    • Strategic Q&A sessions
    • Go-to-market recommendations
    • NDA-protected engagement

    Customize This Report

    Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.